GovChime
IDVOther than small business

IDC (single-award IDV) HHSF223201610004IBIOPHARMA SERVICES USA

Overview

Award facts

Obligated on orders under this IDV
$8.51M
$8,514,505 across 4 orders
Period of performance
From Feb 11, 2016
Modifications
5
Latest action Aug 4, 2020
Contract type
IDC (single-award IDV)
PIID HHSF223201610004I

Description of requirement

IGF::OT::IGF - IDIQ CONTRACT ENTITLED "VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS".

Dates and value

Award date
Signed on Feb 11, 2016
Ordering period ends
May 15, 2021
Ceiling
Ceiling (single-award vehicle): $20,000,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 4, 2020. View on USAspending · Recipient on SAM.gov

Recipient

LocationCOLUMBIA, MO
UEIDRLXCANKKNN6
CAGE code7G0A9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS

Classification and competition

Classification

Product or service (PSC)
B528SPECIAL STUDIES/ANALYSIS- REGULATORY (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
4

Solicitation and notices

Solicitation ID
FDASOL1146520(as reported)

Contract details

Subcontracting plan
Commercial subcontract planG
Major program
In vivo study of generic drug products in human subjects
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial itemA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Feb 11, 2016Base obligation at award: $2,500
Latest action
Aug 4, 2020 — Other administrative actionModification P00005; administrative: no change in scope or value
Latest substantive action
Aug 4, 2020 — Option exercisedModification P00004
Actions by type
  • Base award1
  • Option exercised4
  • Other administrative action1
6 actions recorded, Feb 11, 2016 to Aug 4, 2020; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / indefinite quantityB
Multiple or single award
Single awardS
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401